TABLE 1.
HIIT (n = 13) | SHAM (n = 14) | |
---|---|---|
Men/women, n (%) | 7 (54)/6 (46) | 6 (43)/8 (57) |
Age (yr) | 52.5 (45.0–60.1) | 58.0 (50.1–65.9) |
BMI (kg·m−2) | 24.3 (21.6–26.9) | 24.0 (22.0–26.1) |
V̇O2peak (mL·kg−1·min−1) | 26.7 (22.3–31.2) | 26.3 (22.4–30.3) |
Cancer sites | ||
Colon/rectum, n (%) | 4 (30.8) | 2 (14.3) |
Stomach, n (%) | 3 (23.1) | 2 (14.3) |
Melanoma, n (%) | 2 (15.4) | 1 (7.1) |
Liver, n (%) | 1 (7.7) | 1 (7.1) |
Pancreas, n (%) | 1 (7.7) | 0 (0) |
Esophagus, n (%) | 1 (7.7) | 1 (7.1) |
Ovary, n (%) | 1 (7.7) | 3 (21.4) |
Myeloma, n (%) | 0 (0) | 2 (14.3) |
Breast, n (%) | 0 (0) | 2 (14.3) |
Lung, n (%) | 0 (0) | 1 (7.1) |
UICC stagea | ||
III, n (%) | 1 (7.7) | 1 (7.1) |
IV, n (%) | 12 (92.3) | 11 (78.6) |
Numbers are given as mean and 95% confidence intervals and absolute numbers and percentages, respectively.
aTwo myeloma-patients of the SHAM not included in UICC data.